Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis

[1]  R. Bank,et al.  The RAGE G82S polymorphism is not associated with rheumatoid arthritis independently of HLA-DRB1*0401. , 2006, Rheumatology.

[2]  C. Tıkız,et al.  Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. , 2005, The Journal of rheumatology.

[3]  P. Gregersen,et al.  The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. , 2005, Atherosclerosis.

[4]  A. Silman,et al.  Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. , 2005, Arthritis and rheumatism.

[5]  Andrej Tarkowski,et al.  Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control , 2005, Arthritis research & therapy.

[6]  N. Goodson,et al.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s , 2005, Annals of the rheumatic diseases.

[7]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[8]  F. Ruschitzka,et al.  Simvastatin improves endothelial function in patients with rheumatoid arthritis. , 2005, Journal of the American College of Cardiology.

[9]  I. McInnes,et al.  Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? , 2005, Arthritis research & therapy.

[10]  N. Wheeldon,et al.  Active inflammatory bowel disease and coronary artery dissection , 2005, Postgraduate Medical Journal.

[11]  G. McColl,et al.  Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[12]  E. Rimm,et al.  Cardiovascular risk factors in women with and without rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[13]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[14]  R. Madhok,et al.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial , 2004, The Lancet.

[15]  O Fitzgerald,et al.  Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. , 2003, Rheumatology.

[16]  M. Andrassy,et al.  Central role of RAGE-dependent neointimal expansion in arterial restenosis. , 2003, The Journal of clinical investigation.

[17]  M. Yamakuchi,et al.  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. , 2003, Arthritis and rheumatism.

[18]  A. Silman,et al.  Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. , 2002, Arthritis and rheumatism.

[19]  B. Joffe,et al.  Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis , 2002, Arthritis research.

[20]  P. Gregersen,et al.  RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response , 2002, Genes and Immunity.

[21]  N. de Vries,et al.  Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. , 2002, Arthritis and rheumatism.

[22]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[23]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[24]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[25]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[26]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[27]  I. Fajardy,et al.  Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[28]  C. Suh,et al.  Lipid profiles in untreated patients with rheumatoid arthritis. , 1999, The Journal of rheumatology.

[29]  A. Hofman,et al.  Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[30]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[31]  P. Shekelle,et al.  How to read radiographs according to the Sharp/van der Heijde method. , 1999 .

[32]  P. Grant,et al.  Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. , 1998, Diabetes.

[33]  R. D. Situnayake,et al.  Dyslipidaemia and rheumatoid arthritis , 1997 .

[34]  T. Ikemura,et al.  Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. , 1994, Genomics.

[35]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[36]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[37]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[38]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[39]  R. Siegel,et al.  Cardiovascular manifestations of systemic lupus erythematosus. , 1985, American heart journal.

[40]  I. Das,et al.  Raised C-reactive protein levels in serum from smokers. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[41]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[42]  H. Makino,et al.  Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[43]  Le-Xin Wang,et al.  Rheumatoid arthritis increases the risk of coronary heart disease via vascular endothelial injuries. , 2004, Medical hypotheses.

[44]  D. M. van der Heijde,et al.  How to read radiographs according to the Sharp/van der Heijde method. , 1999, The Journal of rheumatology.

[45]  R. D. Situnayake,et al.  Dyslipidemia and rheumatoid arthritis. , 1997, Annals of the rheumatic diseases.

[46]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.